In vitro activity of three different antimicrobial agents against ESBL producing Escherichia coli and Klebsiella pneumoniae blood isolates

Babini, 2000, Antimicrobial resistance amongst Klebsiella spp. collected from intensive care unit in Southern and Western Europe in 1997–1998, J. Antimicrob. Chemother., 45, 183, 10.1093/jac/45.2.183 Emery, 1997, Detection and clinical significance of extended-spectrum β-lactamases in a tertiary-care medical center, J. Clin. Microbiol., 35, 2061, 10.1128/JCM.35.8.2061-2067.1997 Essack, 2000, Treatment options for extended-spectrum β-lactamase-producers, FEMS Microbiol. Lett., 190, 181 Goossens, 2001, MYSTIC program, Diagn. Microbiol. Infect. Dis., 41, 183, 10.1016/S0732-8893(01)00320-0 Günseren, 1999, A survelliance study of antimicrobial resistance of Gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey, J. Antimicrob. Chemother., 43, 373, 10.1093/jac/43.3.373 Hadziyannis, 2000, Screening and confirmatory testing for extended spectrum β-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca clinical isolates, Diagn. Microbiol. Infect. Dis., 36, 113, 10.1016/S0732-8893(99)00117-0 Jacoby, 1997, Extended-spectrum β-lactamases and other enzymes providing resistance to oxyimino-β-lactams, Infect. Dis. Clin. North. Am., 11, 875, 10.1016/S0891-5520(05)70395-0 Jorgensen, 2003, Susceptibility test methods Koneman, 1997 Lautenbach, 2001, Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-Lactamase-producing Escherichia coli and Klebsiella pneumoniae, Clin. Infect. Dis., 33, 1288, 10.1086/322667 Leblebicioglu, 2002, Survelliance of antimicrobial resistance in Gram-negative isolates from intensive care units in in Turkey, J. Chemother., 14, 140, 10.1179/joc.2002.14.2.140 Livermore, 1995, β-lactamases in laboratory and clinical resistance, Clin. Microbiol. Rev., 8, 557, 10.1128/CMR.8.4.557 Livermore, 2001, Detection of β-lactamase-mediated resistance, J. Antimicrob. Chemother., 48, 59, 10.1093/jac/48.suppl_1.59 Mayer, 1995, Mechanisms of antibiotic resistance National Committee for Clinical Laboratory Standards, 2002. Performance standards for antimicrobial Susceptibility Testing; 12th Informational Supplement. Document 21(1). Palucha, 1999, Concurrent outbreak of extended-spectrum β-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital, J. Antimicrob. Chemother., 44, 489, 10.1093/jac/44.4.489 Paterson, 2000, Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs), Clin. Microbiol. Infect., 6, 460, 10.1046/j.1469-0691.2000.00107.x Paterson, 2000, Epidemiology of ciprofloxacine resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia, Clin. Infect. Dis., 30, 473, 10.1086/313719 Patterson, 2001, Antibiotic utilization. Is there an effect on antimicrobial resistance?, Chest, 119, 426, 10.1378/chest.119.2_suppl.426S Pena, 1995, Relationship between quinolone use and emergence of ciprofloxacine-resistant Escherichia coli in bloodstream infections, Antimicrob. Agents. Chemoter., 39, 520, 10.1128/AAC.39.2.520 Quale, 2002, Molecular epidemiology of a citywide outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection, Clin. Infect Dis., 35, 834, 10.1086/342577 Rice, 2001, Evolution and clinical importance of extended spectrum beta lactamases, Chest, 119, 391, 10.1378/chest.119.2_suppl.391S Sanchez, 2000, Activity of nine antimicrobial agents against clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases and deficient or not porin, J. Antimicrob. Chemother., 46, 858, 10.1093/jac/46.5.858 Sekowska, A., et al., 2002. Resistance of Klebsiella pneumoniae strains producing and not producing ESBL (extended-spectrum beta-lactamase) type enzymes to selected non-beta-lactam antibitotics. Med. Sci. Monit. 8, BR100–104. Shen, 2001, Short communication. Characterization of extended spectrum β-lactamase-producing Klebsiella pneumoniae from Beijing, China, Int. J. Antimicrob. Agents, 8, 185, 10.1016/S0924-8579(01)00351-X Watanabe, 1990, In vitro emergence of quinolone-resistant mutants of Escherichia coli, Enterobacter cloacae, and Serratia marcescens, Antimicrob. Agents Chemother., 34, 173, 10.1128/AAC.34.1.173